Home » Stocks » RVPH

Reviva Pharmaceuticals Holdings, Inc. (RVPH)

Stock Price: $4.83 USD 0.14 (2.99%)
Updated May 14, 2021 4:00 PM EDT - Market closed
After-hours: $4.99 +0.16 (3.31%) May 14, 7:28 PM
Market Cap 44.59M
Revenue (ttm) n/a
Net Income (ttm) -3.78M
Shares Out 9.23M
EPS (ttm) -1.24
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 14
Last Price $4.83
Previous Close $4.69
Change ($) 0.14
Change (%) 2.99%
Day's Open 4.69
Day's Range 4.69 - 5.00
Day's Volume 75,024
52-Week Range 3.93 - 15.10

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Today, investors in RVPH stock saw some pretty massive gains, as the company announced impressive results for its schizophrenia drug. The post RVPH Stock: Why Reviva Pharmaceuticals Is Skyrocketing 90% ...

2 weeks ago - InvestorPlace

Voyager Therapeutics, Inc. (NASDAQ: VYGR), uniQure N.V. (NASDAQ: QURE), Axsome Therapeutics, Inc. (NASDAQ: AXSM), Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) and CRISPR Therapeutics AG (NASDAQCR...

Other stocks mentioned: AXSM, QURE, VYGR, CRSP
2 weeks ago - Benzinga

Shares of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) more than doubled in value Monday after the clinical-stage biopharmaceutical company reported encouraging phase 2 clinical trial results fo...

2 weeks ago - Invezz

Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) has announced the full details of its Phase 2 trial evaluating its lead drug candidate, RP5063 (brilaroxazine), for Acute Schizophrenia. Brilaroxazine ...

2 weeks ago - Benzinga

CUPERTINO, Calif., April 26, 2021 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (along with its subsidiaries, “Reviva” or the “Company”), a clinical-stage pharmaceutical compa...

2 weeks ago - GlobeNewsWire

-Closed Merger with Tenzing Acquisition Corp and publicly listed on  NASDAQ Capital Market-

1 month ago - GlobeNewsWire

Combined Company to Trade on NASDAQ Post-closing under Tickers: RVPH and RVPHW

Other stocks mentioned: TZAC
5 months ago - GlobeNewsWire

NEW YORK, Sept. 14, 2020 /PRNewswire/ -- Tenzing Acquisition Corp.

Other stocks mentioned: TZAC
8 months ago - PRNewsWire

New York, New York--(Newsfile Corp. - July 24, 2020) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who own Tenzing Acquisition Corp.

Other stocks mentioned: TZAC
9 months ago - Newsfile Corp

About RVPH

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 that has completed Phase II clinical trials for the treatment of schizophrenia, as well as completed Phase I clinical trials for treating bipolar disorder, major depressive disorder, behavioral and ps... [Read more...]

Industry
Biotechnology
Founded
2006
Stock Exchange
NASDAQ
Ticker Symbol
RVPH
Full Company Profile

Financial Performance

Financial Statements